What are the recommended treatments for central sensitization syndrome?

Treatment of Central Sensitization Syndrome

Central sensitization syndrome (CSS) requires a multimodal treatment approach prioritizing centrally-acting medications as first-line therapy, combined with non-pharmacological interventions including pain neuroscience education, cognitive-behavioral strategies, and graded exercise therapy. 1, 2

Pharmacological Treatment Algorithm

First-Line Agents

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) should be initiated as the primary pharmacological treatment for CSS. 3, 2

• Duloxetine is the most strongly recommended agent, with demonstrated efficacy in reducing neuropathic pain (59% vs 38% placebo response rate) 3

  • Dosing: Start 30 mg/day for 1 week, then increase to 60 mg/day 3
  • Particularly effective for pain associated with central sensitization mechanisms 3

• Venlafaxine can be considered as an alternative SNRI 3

  • Dosing: 50 mg initially, followed by 37.5 mg twice daily 3
  • Demonstrated efficacy in small randomized trials 3

Second-Line Agents (if SNRIs fail or are contraindicated)

Anticonvulsants targeting α2δ calcium channels should be the next option. 3

• Pregabalin 3

  • Target dose: 300 mg twice daily 3
  • FDA-approved for fibromyalgia, which shares central sensitization mechanisms 3
  • Provides 30-50% pain relief based on Brief Pain Inventory scores 3

• Gabapentin 3

  • Target dose: 300 mg twice daily, can titrate to 1200-3600 mg/day 3
  • Established efficacy for neuropathic pain conditions 3

Tricyclic Antidepressants (TCAs) are alternative second-line options. 3

• Nortriptyline is preferred over amitriptyline due to superior side effect profile 3

  • Start 10-25 mg at bedtime, increase every 3-7 days to 25-100 mg as tolerated 3
  • Common side effects: dry mouth, constipation, sedation 3

• Amitriptyline 3

  • Starting dose: 10-25 mg/day 3
  • Demonstrated efficacy in post-herpetic neuralgia within 3 weeks 3

Third-Line/Salvage Options

Opioids should only be used as salvage therapy when first and second-line treatments fail. 3

• Tramadol (200-400 mg in extended release formulation) has dual mechanism as opioid and SNRI 3

  • NNT: 4.7 for neuropathic pain 3

• Strong opioids at smallest effective dose 3

  • NNT: 4.3 for neuropathic pain 3
  • Caution: Significant risk of physical dependency; not recommended for long-term CSS management 3

Critical Treatment Principles

All centrally-acting medications must be trialed at appropriate doses for at least 2 weeks before determining efficacy or switching agents. 3

Early pain management is of utmost importance to prevent further central sensitization. 3

Topical Interventions

For localized symptoms, topical therapies can be considered as adjuncts: 3

• 1% menthol cream applied twice daily to affected areas showed substantial pain relief (P < 0.001) 3
• Capsaicin 8% patches for 30-60 minutes, with effects lasting 90 days 3
• Topical baclofen/amitriptyline/ketamine gel (10 mg/40 mg/20 mg) showed effects on motor subscales 3

Non-Pharmacological Interventions

Pain neuroscience education must be integrated into the treatment plan to help patients understand central sensitization mechanisms. 2, 4, 5

Graded exercise therapy and functional training should begin early, targeting coordination, sensorimotor function, and cardiovascular conditioning. 3, 2

• Physical exercise reduces CSS symptoms through multiple mechanisms 3
• Vibration training and coordination exercises are particularly beneficial 3
• Exercise can restore exercise-induced hypoalgesia, which is often impaired in CSS 6

Cognitive-behavioral therapy (CBT) targeting pain catastrophizing, sleep disturbance, anxiety, and depression is essential. 3, 2, 4

• Depression and anxiety are strong negative predictors of treatment response 3
• Sleep management should be addressed as sleep disturbance aggravates central sensitization 3

Acupuncture may be considered in selected patients. 3

• Recent randomized trials show encouraging results 3
• Adverse events are mild and infrequent 3

Multidisciplinary Pain Rehabilitation

For severe, refractory CSS with significant functional impairment, comprehensive pain rehabilitation programs should be considered. 3

• 3-week intensive programs combining physical therapy, occupational therapy, and psychological support 3
• Focus on physical reconditioning, activity tolerance, and tapering pain medications 3
• Demonstrated effectiveness in improving physical and emotional functioning 3

Common Pitfalls to Avoid

Do not use NSAIDs or glucocorticoids as primary treatment—there is no evidence supporting their benefit in CSS. 3

Do not focus solely on short-term pain relief; treatment goals must emphasize long-term functional improvement and quality of life. 2

Do not overlook comorbid conditions that amplify central sensitization: 3

• Fibromyalgia
• Irritable bowel syndrome
• Mood disorders (depression/anxiety)
• Sleep disorders
• Autonomic dysfunction 7, 8

Recognize that CSS and peripheral pathology often coexist—both require treatment. 1, 8

Emerging Considerations

Metabolic interventions (ketogenic diets) and targeting neurotrophic factors (brain-derived neurotrophic factor) represent promising future directions. 4

Stress management and dietary interventions may provide additional benefits as part of comprehensive treatment. 2, 4